Index
1 Tenofovir Fumarate Market Overview
1.1 Product Overview and Scope of Tenofovir Fumarate
1.2 Tenofovir Fumarate Segment by Type
1.2.1 Global Tenofovir Fumarate Market Value Comparison by Type (2024-2030)
1.2.2 30 Pcs/Box
1.2.3 10 Pcs/Box
1.2.4 Others
1.3 Tenofovir Fumarate Segment by Application
1.3.1 Global Tenofovir Fumarate Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Scientific Research Institutions
1.4 Global Tenofovir Fumarate Market Size Estimates and Forecasts
1.4.1 Global Tenofovir Fumarate Revenue 2019-2030
1.4.2 Global Tenofovir Fumarate Sales 2019-2030
1.4.3 Global Tenofovir Fumarate Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Tenofovir Fumarate Market Competition by Manufacturers
2.1 Global Tenofovir Fumarate Sales Market Share by Manufacturers (2019-2024)
2.2 Global Tenofovir Fumarate Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Tenofovir Fumarate Average Price by Manufacturers (2019-2024)
2.4 Global Tenofovir Fumarate Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Tenofovir Fumarate, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tenofovir Fumarate, Product Type & Application
2.7 Tenofovir Fumarate Market Competitive Situation and Trends
2.7.1 Tenofovir Fumarate Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Tenofovir Fumarate Players Market Share by Revenue
2.7.3 Global Tenofovir Fumarate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Tenofovir Fumarate Retrospective Market Scenario by Region
3.1 Global Tenofovir Fumarate Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Tenofovir Fumarate Global Tenofovir Fumarate Sales by Region: 2019-2030
3.2.1 Global Tenofovir Fumarate Sales by Region: 2019-2024
3.2.2 Global Tenofovir Fumarate Sales by Region: 2025-2030
3.3 Global Tenofovir Fumarate Global Tenofovir Fumarate Revenue by Region: 2019-2030
3.3.1 Global Tenofovir Fumarate Revenue by Region: 2019-2024
3.3.2 Global Tenofovir Fumarate Revenue by Region: 2025-2030
3.4 North America Tenofovir Fumarate Market Facts & Figures by Country
3.4.1 North America Tenofovir Fumarate Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Tenofovir Fumarate Sales by Country (2019-2030)
3.4.3 North America Tenofovir Fumarate Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Tenofovir Fumarate Market Facts & Figures by Country
3.5.1 Europe Tenofovir Fumarate Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Tenofovir Fumarate Sales by Country (2019-2030)
3.5.3 Europe Tenofovir Fumarate Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Tenofovir Fumarate Market Facts & Figures by Country
3.6.1 Asia Pacific Tenofovir Fumarate Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Tenofovir Fumarate Sales by Country (2019-2030)
3.6.3 Asia Pacific Tenofovir Fumarate Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Tenofovir Fumarate Market Facts & Figures by Country
3.7.1 Latin America Tenofovir Fumarate Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Tenofovir Fumarate Sales by Country (2019-2030)
3.7.3 Latin America Tenofovir Fumarate Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Tenofovir Fumarate Market Facts & Figures by Country
3.8.1 Middle East and Africa Tenofovir Fumarate Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Tenofovir Fumarate Sales by Country (2019-2030)
3.8.3 Middle East and Africa Tenofovir Fumarate Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tenofovir Fumarate Sales by Type (2019-2030)
4.1.1 Global Tenofovir Fumarate Sales by Type (2019-2024)
4.1.2 Global Tenofovir Fumarate Sales by Type (2025-2030)
4.1.3 Global Tenofovir Fumarate Sales Market Share by Type (2019-2030)
4.2 Global Tenofovir Fumarate Revenue by Type (2019-2030)
4.2.1 Global Tenofovir Fumarate Revenue by Type (2019-2024)
4.2.2 Global Tenofovir Fumarate Revenue by Type (2025-2030)
4.2.3 Global Tenofovir Fumarate Revenue Market Share by Type (2019-2030)
4.3 Global Tenofovir Fumarate Price by Type (2019-2030)
5 Segment by Application
5.1 Global Tenofovir Fumarate Sales by Application (2019-2030)
5.1.1 Global Tenofovir Fumarate Sales by Application (2019-2024)
5.1.2 Global Tenofovir Fumarate Sales by Application (2025-2030)
5.1.3 Global Tenofovir Fumarate Sales Market Share by Application (2019-2030)
5.2 Global Tenofovir Fumarate Revenue by Application (2019-2030)
5.2.1 Global Tenofovir Fumarate Revenue by Application (2019-2024)
5.2.2 Global Tenofovir Fumarate Revenue by Application (2025-2030)
5.2.3 Global Tenofovir Fumarate Revenue Market Share by Application (2019-2030)
5.3 Global Tenofovir Fumarate Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Toronto Research Chemicals
6.1.1 Toronto Research Chemicals Corporation Information
6.1.2 Toronto Research Chemicals Description and Business Overview
6.1.3 Toronto Research Chemicals Tenofovir Fumarate Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Toronto Research Chemicals Tenofovir Fumarate Product Portfolio
6.1.5 Toronto Research Chemicals Recent Developments/Updates
6.2 BOC Sciences
6.2.1 BOC Sciences Corporation Information
6.2.2 BOC Sciences Description and Business Overview
6.2.3 BOC Sciences Tenofovir Fumarate Sales, Revenue and Gross Margin (2019-2024)
6.2.4 BOC Sciences Tenofovir Fumarate Product Portfolio
6.2.5 BOC Sciences Recent Developments/Updates
6.3 Glaxo SmithKline
6.3.1 Glaxo SmithKline Corporation Information
6.3.2 Glaxo SmithKline Description and Business Overview
6.3.3 Glaxo SmithKline Tenofovir Fumarate Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Glaxo SmithKline Tenofovir Fumarate Product Portfolio
6.3.5 Glaxo SmithKline Recent Developments/Updates
6.4 Gilead Sciences
6.4.1 Gilead Sciences Corporation Information
6.4.2 Gilead Sciences Description and Business Overview
6.4.3 Gilead Sciences Tenofovir Fumarate Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Gilead Sciences Tenofovir Fumarate Product Portfolio
6.4.5 Gilead Sciences Recent Developments/Updates
6.5 Emcure Pharmaceuticals Limited
6.5.1 Emcure Pharmaceuticals Limited Corporation Information
6.5.2 Emcure Pharmaceuticals Limited Description and Business Overview
6.5.3 Emcure Pharmaceuticals Limited Tenofovir Fumarate Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Emcure Pharmaceuticals Limited Tenofovir Fumarate Product Portfolio
6.5.5 Emcure Pharmaceuticals Limited Recent Developments/Updates
6.6 Natco Pharma
6.6.1 Natco Pharma Corporation Information
6.6.2 Natco Pharma Description and Business Overview
6.6.3 Natco Pharma Tenofovir Fumarate Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Natco Pharma Tenofovir Fumarate Product Portfolio
6.6.5 Natco Pharma Recent Developments/Updates
6.7 Viatris Inc
6.6.1 Viatris Inc Corporation Information
6.6.2 Viatris Inc Description and Business Overview
6.6.3 Viatris Inc Tenofovir Fumarate Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Viatris Inc Tenofovir Fumarate Product Portfolio
6.7.5 Viatris Inc Recent Developments/Updates
6.8 HBCChem
6.8.1 HBCChem Corporation Information
6.8.2 HBCChem Description and Business Overview
6.8.3 HBCChem Tenofovir Fumarate Sales, Revenue and Gross Margin (2019-2024)
6.8.4 HBCChem Tenofovir Fumarate Product Portfolio
6.8.5 HBCChem Recent Developments/Updates
6.9 Shang Enda Biotechnology
6.9.1 Shang Enda Biotechnology Corporation Information
6.9.2 Shang Enda Biotechnology Description and Business Overview
6.9.3 Shang Enda Biotechnology Tenofovir Fumarate Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Shang Enda Biotechnology Tenofovir Fumarate Product Portfolio
6.9.5 Shang Enda Biotechnology Recent Developments/Updates
6.10 T&W Group
6.10.1 T&W Group Corporation Information
6.10.2 T&W Group Description and Business Overview
6.10.3 T&W Group Tenofovir Fumarate Sales, Revenue and Gross Margin (2019-2024)
6.10.4 T&W Group Tenofovir Fumarate Product Portfolio
6.10.5 T&W Group Recent Developments/Updates
6.11 Huilun Pharmaceutical Co., Ltd
6.11.1 Huilun Pharmaceutical Co., Ltd Corporation Information
6.11.2 Huilun Pharmaceutical Co., Ltd Tenofovir Fumarate Description and Business Overview
6.11.3 Huilun Pharmaceutical Co., Ltd Tenofovir Fumarate Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Huilun Pharmaceutical Co., Ltd Tenofovir Fumarate Product Portfolio
6.11.5 Huilun Pharmaceutical Co., Ltd Recent Developments/Updates
6.12 Hefei Topway Biotechnology Co., Ltd
6.12.1 Hefei Topway Biotechnology Co., Ltd Corporation Information
6.12.2 Hefei Topway Biotechnology Co., Ltd Tenofovir Fumarate Description and Business Overview
6.12.3 Hefei Topway Biotechnology Co., Ltd Tenofovir Fumarate Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Hefei Topway Biotechnology Co., Ltd Tenofovir Fumarate Product Portfolio
6.12.5 Hefei Topway Biotechnology Co., Ltd Recent Developments/Updates
6.13 Supor Pharmaceutical Co., Ltd
6.13.1 Supor Pharmaceutical Co., Ltd Corporation Information
6.13.2 Supor Pharmaceutical Co., Ltd Tenofovir Fumarate Description and Business Overview
6.13.3 Supor Pharmaceutical Co., Ltd Tenofovir Fumarate Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Supor Pharmaceutical Co., Ltd Tenofovir Fumarate Product Portfolio
6.13.5 Supor Pharmaceutical Co., Ltd Recent Developments/Updates
6.14 Qilu Pharmaceutical Co., Ltd
6.14.1 Qilu Pharmaceutical Co., Ltd Corporation Information
6.14.2 Qilu Pharmaceutical Co., Ltd Tenofovir Fumarate Description and Business Overview
6.14.3 Qilu Pharmaceutical Co., Ltd Tenofovir Fumarate Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Qilu Pharmaceutical Co., Ltd Tenofovir Fumarate Product Portfolio
6.14.5 Qilu Pharmaceutical Co., Ltd Recent Developments/Updates
6.15 Carelife Pharmaceutical Co., Ltd
6.15.1 Carelife Pharmaceutical Co., Ltd Corporation Information
6.15.2 Carelife Pharmaceutical Co., Ltd Tenofovir Fumarate Description and Business Overview
6.15.3 Carelife Pharmaceutical Co., Ltd Tenofovir Fumarate Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Carelife Pharmaceutical Co., Ltd Tenofovir Fumarate Product Portfolio
6.15.5 Carelife Pharmaceutical Co., Ltd Recent Developments/Updates
6.16 Anke Hengyi Pharmaceutical Co., Ltd
6.16.1 Anke Hengyi Pharmaceutical Co., Ltd Corporation Information
6.16.2 Anke Hengyi Pharmaceutical Co., Ltd Tenofovir Fumarate Description and Business Overview
6.16.3 Anke Hengyi Pharmaceutical Co., Ltd Tenofovir Fumarate Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Anke Hengyi Pharmaceutical Co., Ltd Tenofovir Fumarate Product Portfolio
6.16.5 Anke Hengyi Pharmaceutical Co., Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tenofovir Fumarate Industry Chain Analysis
7.2 Tenofovir Fumarate Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tenofovir Fumarate Production Mode & Process
7.4 Tenofovir Fumarate Sales and Marketing
7.4.1 Tenofovir Fumarate Sales Channels
7.4.2 Tenofovir Fumarate Distributors
7.5 Tenofovir Fumarate Customers
8 Tenofovir Fumarate Market Dynamics
8.1 Tenofovir Fumarate Industry Trends
8.2 Tenofovir Fumarate Market Drivers
8.3 Tenofovir Fumarate Market Challenges
8.4 Tenofovir Fumarate Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
List of Tables
Table 1. Global Tenofovir Fumarate Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Tenofovir Fumarate Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Tenofovir Fumarate Market Competitive Situation by Manufacturers in 2023
Table 4. Global Tenofovir Fumarate Sales (Units) of Key Manufacturers (2019-2024)
Table 5. Global Tenofovir Fumarate Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Tenofovir Fumarate Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Tenofovir Fumarate Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Tenofovir Fumarate Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Tenofovir Fumarate, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Tenofovir Fumarate, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Tenofovir Fumarate, Product Type & Application
Table 12. Global Key Manufacturers of Tenofovir Fumarate, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Tenofovir Fumarate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tenofovir Fumarate as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Tenofovir Fumarate Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Tenofovir Fumarate Sales by Region (2019-2024) & (Units)
Table 18. Global Tenofovir Fumarate Sales Market Share by Region (2019-2024)
Table 19. Global Tenofovir Fumarate Sales by Region (2025-2030) & (Units)
Table 20. Global Tenofovir Fumarate Sales Market Share by Region (2025-2030)
Table 21. Global Tenofovir Fumarate Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Tenofovir Fumarate Revenue Market Share by Region (2019-2024)
Table 23. Global Tenofovir Fumarate Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Tenofovir Fumarate Revenue Market Share by Region (2025-2030)
Table 25. North America Tenofovir Fumarate Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Tenofovir Fumarate Sales by Country (2019-2024) & (Units)
Table 27. North America Tenofovir Fumarate Sales by Country (2025-2030) & (Units)
Table 28. North America Tenofovir Fumarate Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Tenofovir Fumarate Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Tenofovir Fumarate Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Tenofovir Fumarate Sales by Country (2019-2024) & (Units)
Table 32. Europe Tenofovir Fumarate Sales by Country (2025-2030) & (Units)
Table 33. Europe Tenofovir Fumarate Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Tenofovir Fumarate Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Tenofovir Fumarate Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Tenofovir Fumarate Sales by Region (2019-2024) & (Units)
Table 37. Asia Pacific Tenofovir Fumarate Sales by Region (2025-2030) & (Units)
Table 38. Asia Pacific Tenofovir Fumarate Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Tenofovir Fumarate Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Tenofovir Fumarate Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Tenofovir Fumarate Sales by Country (2019-2024) & (Units)
Table 42. Latin America Tenofovir Fumarate Sales by Country (2025-2030) & (Units)
Table 43. Latin America Tenofovir Fumarate Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Tenofovir Fumarate Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Tenofovir Fumarate Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Tenofovir Fumarate Sales by Country (2019-2024) & (Units)
Table 47. Middle East & Africa Tenofovir Fumarate Sales by Country (2025-2030) & (Units)
Table 48. Middle East & Africa Tenofovir Fumarate Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Tenofovir Fumarate Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Tenofovir Fumarate Sales (Units) by Type (2019-2024)
Table 51. Global Tenofovir Fumarate Sales (Units) by Type (2025-2030)
Table 52. Global Tenofovir Fumarate Sales Market Share by Type (2019-2024)
Table 53. Global Tenofovir Fumarate Sales Market Share by Type (2025-2030)
Table 54. Global Tenofovir Fumarate Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Tenofovir Fumarate Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Tenofovir Fumarate Revenue Market Share by Type (2019-2024)
Table 57. Global Tenofovir Fumarate Revenue Market Share by Type (2025-2030)
Table 58. Global Tenofovir Fumarate Price (US$/Unit) by Type (2019-2024)
Table 59. Global Tenofovir Fumarate Price (US$/Unit) by Type (2025-2030)
Table 60. Global Tenofovir Fumarate Sales (Units) by Application (2019-2024)
Table 61. Global Tenofovir Fumarate Sales (Units) by Application (2025-2030)
Table 62. Global Tenofovir Fumarate Sales Market Share by Application (2019-2024)
Table 63. Global Tenofovir Fumarate Sales Market Share by Application (2025-2030)
Table 64. Global Tenofovir Fumarate Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Tenofovir Fumarate Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Tenofovir Fumarate Revenue Market Share by Application (2019-2024)
Table 67. Global Tenofovir Fumarate Revenue Market Share by Application (2025-2030)
Table 68. Global Tenofovir Fumarate Price (US$/Unit) by Application (2019-2024)
Table 69. Global Tenofovir Fumarate Price (US$/Unit) by Application (2025-2030)
Table 70. Toronto Research Chemicals Corporation Information
Table 71. Toronto Research Chemicals Description and Business Overview
Table 72. Toronto Research Chemicals Tenofovir Fumarate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Toronto Research Chemicals Tenofovir Fumarate Product
Table 74. Toronto Research Chemicals Recent Developments/Updates
Table 75. BOC Sciences Corporation Information
Table 76. BOC Sciences Description and Business Overview
Table 77. BOC Sciences Tenofovir Fumarate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. BOC Sciences Tenofovir Fumarate Product
Table 79. BOC Sciences Recent Developments/Updates
Table 80. Glaxo SmithKline Corporation Information
Table 81. Glaxo SmithKline Description and Business Overview
Table 82. Glaxo SmithKline Tenofovir Fumarate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Glaxo SmithKline Tenofovir Fumarate Product
Table 84. Glaxo SmithKline Recent Developments/Updates
Table 85. Gilead Sciences Corporation Information
Table 86. Gilead Sciences Description and Business Overview
Table 87. Gilead Sciences Tenofovir Fumarate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Gilead Sciences Tenofovir Fumarate Product
Table 89. Gilead Sciences Recent Developments/Updates
Table 90. Emcure Pharmaceuticals Limited Corporation Information
Table 91. Emcure Pharmaceuticals Limited Description and Business Overview
Table 92. Emcure Pharmaceuticals Limited Tenofovir Fumarate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Emcure Pharmaceuticals Limited Tenofovir Fumarate Product
Table 94. Emcure Pharmaceuticals Limited Recent Developments/Updates
Table 95. Natco Pharma Corporation Information
Table 96. Natco Pharma Description and Business Overview
Table 97. Natco Pharma Tenofovir Fumarate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Natco Pharma Tenofovir Fumarate Product
Table 99. Natco Pharma Recent Developments/Updates
Table 100. Viatris Inc Corporation Information
Table 101. Viatris Inc Description and Business Overview
Table 102. Viatris Inc Tenofovir Fumarate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Viatris Inc Tenofovir Fumarate Product
Table 104. Viatris Inc Recent Developments/Updates
Table 105. HBCChem Corporation Information
Table 106. HBCChem Description and Business Overview
Table 107. HBCChem Tenofovir Fumarate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. HBCChem Tenofovir Fumarate Product
Table 109. HBCChem Recent Developments/Updates
Table 110. Shang Enda Biotechnology Corporation Information
Table 111. Shang Enda Biotechnology Description and Business Overview
Table 112. Shang Enda Biotechnology Tenofovir Fumarate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Shang Enda Biotechnology Tenofovir Fumarate Product
Table 114. Shang Enda Biotechnology Recent Developments/Updates
Table 115. T&W Group Corporation Information
Table 116. T&W Group Description and Business Overview
Table 117. T&W Group Tenofovir Fumarate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. T&W Group Tenofovir Fumarate Product
Table 119. T&W Group Recent Developments/Updates
Table 120. Huilun Pharmaceutical Co., Ltd Corporation Information
Table 121. Huilun Pharmaceutical Co., Ltd Description and Business Overview
Table 122. Huilun Pharmaceutical Co., Ltd Tenofovir Fumarate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Huilun Pharmaceutical Co., Ltd Tenofovir Fumarate Product
Table 124. Huilun Pharmaceutical Co., Ltd Recent Developments/Updates
Table 125. Hefei Topway Biotechnology Co., Ltd Corporation Information
Table 126. Hefei Topway Biotechnology Co., Ltd Description and Business Overview
Table 127. Hefei Topway Biotechnology Co., Ltd Tenofovir Fumarate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Hefei Topway Biotechnology Co., Ltd Tenofovir Fumarate Product
Table 129. Hefei Topway Biotechnology Co., Ltd Recent Developments/Updates
Table 130. Supor Pharmaceutical Co., Ltd Corporation Information
Table 131. Supor Pharmaceutical Co., Ltd Description and Business Overview
Table 132. Supor Pharmaceutical Co., Ltd Tenofovir Fumarate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Supor Pharmaceutical Co., Ltd Tenofovir Fumarate Product
Table 134. Supor Pharmaceutical Co., Ltd Recent Developments/Updates
Table 135. Qilu Pharmaceutical Co., Ltd Corporation Information
Table 136. Qilu Pharmaceutical Co., Ltd Description and Business Overview
Table 137. Qilu Pharmaceutical Co., Ltd Tenofovir Fumarate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Qilu Pharmaceutical Co., Ltd Tenofovir Fumarate Product
Table 139. Qilu Pharmaceutical Co., Ltd Recent Developments/Updates
Table 140. Carelife Pharmaceutical Co., Ltd Corporation Information
Table 141. Carelife Pharmaceutical Co., Ltd Description and Business Overview
Table 142. Carelife Pharmaceutical Co., Ltd Tenofovir Fumarate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Carelife Pharmaceutical Co., Ltd Tenofovir Fumarate Product
Table 144. Carelife Pharmaceutical Co., Ltd Recent Developments/Updates
Table 145. Anke Hengyi Pharmaceutical Co., Ltd Corporation Information
Table 146. Anke Hengyi Pharmaceutical Co., Ltd Description and Business Overview
Table 147. Anke Hengyi Pharmaceutical Co., Ltd Tenofovir Fumarate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Anke Hengyi Pharmaceutical Co., Ltd Tenofovir Fumarate Product
Table 149. Anke Hengyi Pharmaceutical Co., Ltd Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Tenofovir Fumarate Distributors List
Table 153. Tenofovir Fumarate Customers List
Table 154. Tenofovir Fumarate Market Trends
Table 155. Tenofovir Fumarate Market Drivers
Table 156. Tenofovir Fumarate Market Challenges
Table 157. Tenofovir Fumarate Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Tenofovir Fumarate
Figure 2. Global Tenofovir Fumarate Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Tenofovir Fumarate Market Share by Type in 2023 & 2030
Figure 4. 30 Pcs/Box Product Picture
Figure 5. 10 Pcs/Box Product Picture
Figure 6. Others Product Picture
Figure 7. Global Tenofovir Fumarate Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Tenofovir Fumarate Market Share by Application in 2023 & 2030
Figure 9. Hospital
Figure 10. Scientific Research Institutions
Figure 11. Global Tenofovir Fumarate Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Tenofovir Fumarate Market Size (2019-2030) & (US$ Million)
Figure 13. Global Tenofovir Fumarate Sales (2019-2030) & (Units)
Figure 14. Global Tenofovir Fumarate Average Price (US$/Unit) & (2019-2030)
Figure 15. Tenofovir Fumarate Report Years Considered
Figure 16. Tenofovir Fumarate Sales Share by Manufacturers in 2023
Figure 17. Global Tenofovir Fumarate Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Tenofovir Fumarate Players: Market Share by Revenue in 2023
Figure 19. Tenofovir Fumarate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Tenofovir Fumarate Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Tenofovir Fumarate Sales Market Share by Country (2019-2030)
Figure 22. North America Tenofovir Fumarate Revenue Market Share by Country (2019-2030)
Figure 23. United States Tenofovir Fumarate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Tenofovir Fumarate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Tenofovir Fumarate Sales Market Share by Country (2019-2030)
Figure 26. Europe Tenofovir Fumarate Revenue Market Share by Country (2019-2030)
Figure 27. Germany Tenofovir Fumarate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Tenofovir Fumarate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Tenofovir Fumarate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Tenofovir Fumarate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Netherlands Tenofovir Fumarate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Tenofovir Fumarate Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Tenofovir Fumarate Revenue Market Share by Region (2019-2030)
Figure 34. China Tenofovir Fumarate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Tenofovir Fumarate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Tenofovir Fumarate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Tenofovir Fumarate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Tenofovir Fumarate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Tenofovir Fumarate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Tenofovir Fumarate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Latin America Tenofovir Fumarate Sales Market Share by Country (2019-2030)
Figure 42. Latin America Tenofovir Fumarate Revenue Market Share by Country (2019-2030)
Figure 43. Mexico Tenofovir Fumarate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Brazil Tenofovir Fumarate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Argentina Tenofovir Fumarate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Colombia Tenofovir Fumarate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Tenofovir Fumarate Sales Market Share by Country (2019-2030)
Figure 48. Middle East & Africa Tenofovir Fumarate Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Tenofovir Fumarate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Tenofovir Fumarate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Tenofovir Fumarate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Tenofovir Fumarate by Type (2019-2030)
Figure 53. Global Revenue Market Share of Tenofovir Fumarate by Type (2019-2030)
Figure 54. Global Tenofovir Fumarate Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of Tenofovir Fumarate by Application (2019-2030)
Figure 56. Global Revenue Market Share of Tenofovir Fumarate by Application (2019-2030)
Figure 57. Global Tenofovir Fumarate Price (US$/Unit) by Application (2019-2030)
Figure 58. Tenofovir Fumarate Value Chain
Figure 59. Tenofovir Fumarate Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed